Connection
Frits Van Rhee to Patient Safety
This is a "connection" page, showing publications Frits Van Rhee has written about Patient Safety.
|
|
Connection Strength |
|
 |
|
 |
|
0.163 |
|
|
|
-
van Rhee F, Casper C, Voorhees PM, Fayad LE, Gibson D, Kanhai K, Kurzrock R. Long-term safety of siltuximab in patients with idiopathic multicentric Castleman disease: a prespecified, open-label, extension analysis of two trials. Lancet Haematol. 2020 Mar; 7(3):e209-e217.
Score: 0.163